Get Live Data

Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

  2. Share Prices
  3. Hikma Pharmaceuticals Share Price
  4. Hikma Pharmaceuticals Share News
  5. UK BROKER RATINGS SUMMARY: Jefferies Raises Raft Of Property Investors

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Hikma Pharmaceuticals Information

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,972.00
Change: 17.00 (0.87%)
Spread: 1.00 (0.051%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS SUMMARY: Jefferies Raises Raft Of Property Investors

Thu, 02nd Apr 2020 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

----------

FTSE 100

----------

JEFFERIES RAISES SEGRO TO 'BUY' ('HOLD') - TARGET 878 (978) PENCE

----------

JEFFERIES RAISES LAND SECURITIES TO 'BUY' ('UNDERPERFORM') - TARGET 640 (800) PENCE

----------

JEFFERIES RAISES BRITISH LAND TO 'HOLD' ('UNDERPERFORM') - TARGET 365 (450) PENCE

----------

BARCLAYS RAISES UNILEVER TO 'EQUAL WEIGHT' ('UNDERWEIGHT') - PRICE TARGET 4420 (4220) PENCE

----------

GOLDMAN CUTS UNILEVER PRICE TARGET TO 4900 (5000) PENCE - 'BUY'

----------

DZ BANK CUTS BP TO 'SELL' (HOLD) - FAIRER WERT 300 (350) PENCE

----------

CREDIT SUISSE CUTS BP PRICE TARGET TO 375 (385) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE CUTS SHELL PRICE TARGET TO 1900 (2050) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE CUTS IAG PENCE PRICE TARGET TO 463 (624) PENCE - 'OUTPERFORM'

----------

MAINFIRST CUTS IAG PRICE TARGET TO 6 (9) EUR - 'BUY'

----------

MAINFIRST CUTS EASYJET TO 'SELL' (HOLD) - PRICE TARGET 450 (1100) PENCE

----------

CREDIT SUISSE CUTS EASYJET PRICE TARGET TO 945 (1555) PENCE - 'OUTPERFORM'

----------

DEUTSCHE BANK CUTS WHITBREAD PRICE TARGET TO 3340 (4550) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS COCA-COLA HBC PRICE TARGET TO 2450 (3250) PENCE - 'BUY'

----------

DEUTSCHE BANK CUTS BURBERRY PRICE TARGET TO 1550 (1700) PENCE - 'HOLD'

----------

RBC CUTS BURBERRY PRICE TARGET TO 1350 (1700) PENCE - 'UNDERPERFORM'

----------

DEUTSCHE BANK CUTS DIAGEO PRICE TARGET TO 2850 (3200) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS JUST EAT TAKEAWAY,COM PRICE TARGET TO 70 (80) PENCE - 'HOLD'

----------

GOLDMAN CUTS RECKITT BENCKISER PRICE TARGET TO 5950 (6000) PENCE - 'NEUTRAL'

----------

CREDIT SUISSE CUTS MEGGITT PRICE TARGET TO 270 (500) PENCE - 'UNDERPERFORM'

----------

UBS CUTS MEGGITT PRICE TARGET TO 241 (379) PENCE - 'SELL'

----------

HSBC RAISES MEGGITT PRICE TARGET TO 315 (300) PENCE - 'BUY'

----------

UBS CUTS MELROSE INDUSTRIES PRICE TARGET TO 128 (235) PENCE - 'BUY'

----------

UBS CUTS ROLLS-ROYCE TO 'NEUTRAL' (BUY) - PRICE TARGET 328 (664) PENCE

----------

JEFFERIES CUTS MONDI PRICE TARGET TO 1650 (1870) PENCE - 'BUY'

----------

JPMORGAN CUTS DS SMITH PRICE TARGET TO 330 (400) PENCE - 'OVERWEIGHT'

----------

JEFFERIES RAISES DS SMITH TO 'BUY' ('HOLD') - TARGET 325 (370) PENCE

----------

BARCLAYS CUTS RSA INSURANCE PRICE TARGET TO 539 (635) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS PRUDENTIAL PRICE TARGET TO 1463 (1749) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS AVIVA PRICE TARGET TO 391 (461) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS RAISES ADMIRAL GROUP PRICE TARGET TO 2376 (2356) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS RBS PRICE TARGET TO 200 (230) PENCE - 'OVERWEIGHT'

----------

JPMORGAN CUTS LLOYDS PRICE TARGET TO 50 (60) PENCE - 'NEUTRAL'

----------

RBC CUTS LLOYDS PRICE TARGET TO 46 (47) PENCE - 'OUTPERFORM'

----------

JPMORGAN CUTS HSBC PRICE TARGET TO 510 (570) PENCE - 'UNDERWEIGHT'

----------

BERNSTEIN CUTS SSE PRICE TARGET TO 1500 (1600) PENCE - 'OUTPERFORM'

----------

CITIGROUP CUTS WPP PRICE TARGET TO 1050 (1150) PENCE - 'BUY'

----------

CITIGROUP CUTS ITV PRICE TARGET TO 95 (105) PENCE - 'BUY'

----------

CREDIT SUISSE CUTS VODAFONE PRICE TARGET TO 170 (190) PENCE - 'OUTPERFORM'

----------

JPMORGAN RAISES HIKMA PHARMA TO 'OVERWEIGHT' ('UNDERWEIGHT') TARGET 2400(1850)P

----------

FTSE 250

----------

JEFFERIES RAISES WORKSPACE GROUP TO 'HOLD' ('UNDERPERFORM') - TARGET 745 (900)P

----------

JEFFERIES RAISES SHAFTESBURY TO 'HOLD' ('UNDERPERFORM') - TARGET 598 (790) P

----------

JEFFERIES RAISES SAFESTORE TO 'BUY' ('HOLD') - TARGET 750 PENCE

----------

JEFFERIES RAISES PRIMARY HEALTH TO 'BUY' ('HOLD') - TARGET 179 (165) PENCE

----------

JEFFERIES RAISES LONDONMETRIC PROPERTY TO 'BUY' ('HOLD') - TARGET 204 (240) P

----------

JEFFERIES CUTS HAMMERSON PRICE TARGET TO 59 (188) PENCE - 'UNDERPERFORM'

----------

JEFFERIES RAISES GREAT PORTLAND TO 'BUY' ('UNDERPERFORM') - TARGET 790 (700) P

----------

JEFFERIES RAISES GRAINGER TO 'BUY' ('HOLD') - TARGET 300 PENCE

----------

JEFFERIES RAISES DERWENT LONDON TO 'BUY' ('UNDERPERFORM') - TARGET 3958 (3600) PENCE

----------

JEFFERIES RAISES CAPITAL & COUNTIES TO 'HOLD' ('UNDERPERFORM') TARGET 172(188)P

----------

JEFFERIES RAISES UNITE GROUP TO 'BUY' ('HOLD') - TARGET 932 (1200) PENCE

----------

JEFFERIES RAISES BIG YELLOW GROUP TO 'BUY' ('HOLD') - TARGET 1164 (1050) PENCE

----------

JEFFERIES RAISES ASSURA GROUP PRICE TARGET TO 94 (79) PENCE - 'BUY'

----------

LIBERUM RAISES IG GROUP PRICE TARGET TO 725 (695) PENCE - 'HOLD'

----------

DEUTSCHE BANK CUTS BRITVIC PRICE TARGET TO 900 (1100) PENCE - 'BUY'

----------

BARCLAYS CUTS SABRE INSURANCE PRICE TARGET TO 273 (278) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS LANCASHIRE HOLDINGS PRICE TARGET TO 678 (781) PENCE - 'EQUAL WEIGHT'

----------

BARCLAYS CUTS HISCOX PRICE TARGET TO 1001 (1231) PENCE - 'UNDERWEIGHT'

----------

BARCLAYS RAISES HASTINGS GROUP PRICE TARGET TO 208 (205) PENCE - 'OVERWEIGHT'

----------

BARCLAYS CUTS DIRECT LINE PRICE TARGET TO 341 (342) PENCE - 'EQUAL WEIGHT'

----------

GOLDMAN CUTS WILLIAM HILL PRICE TARGET TO 120 (200) PENCE - 'NEUTRAL'

----------

GOLDMAN CUTS GVC HOLDING PRICE TARGET TO 975 (1170) PENCE - 'BUY'

----------

JPMORGAN CUTS SSP GROUP PRICE TARGET TO 515 (730) PENCE - 'OVERWEIGHT'

----------

OTHER MAIN MARKET AND AIM

----------

MAINFIRST CUTS RYANAIR PRICE TARGET TO 11.50 (14.50) EUR - 'BUY'

----------

CREDIT SUISSE CUTS RYANAIR PRICE TARGET TO 11.90 (14.16) EUR - 'OUTPERFORM'

----------

DEUTSCHE BANK CUTS FEVERTREE DRINKS PRICE TARGET TO 1250 (1650) PENCE - 'HOLD'

----------

JEFFERIES CUTS INTU PROPERTIES PRICE TARGET TO 3 (5) PENCE - 'UNDERPERFORM'

----------

JPMORGAN CUTS BANK OF IRELAND PRICE TARGET TO 3,60 (5,40) EUR - 'NEUTRAL'

----------

JPMORGAN CUTS ALLIED IRISH BANKS PRICE TARGET TO 1,90 (2,70) EUR - 'OVERWEIGHT'

----------

CITIGROUP CUTS DAILY MAIL PRICE TARGET TO 625 (685) PENCE - 'SELL'

----------

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
6 Mar 2023 09:48

LONDON BROKER RATINGS: DB cuts Reckitt; Jefferies likes Tesco

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
12345678910

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.